The faulty containment valve

Published: 9-Jun-2017

A case of mistaken identity?

You need to be a subscriber to read this article.
Click here to find out more.

Containment issues are becoming an increasingly important aspect of solid dosage form production, especially for highly potent and toxic active pharmaceutical ingredients (APIs) for hormone and oncology applications.

With a more intense focus on health and safety, avoiding both operator exposure and preventing cross-contamination has never been more critical.

GEA’s BUCK MC valves offer a modular, off-the-shelf solution for a variety of powder handling needs, facilitating fast product changeovers and the contained charging/discharging of potent actives from one vessel to another.

Occasionally, however, with time and use, problems can occur. Yet, working with GEA means partnering with a dedicated team of service experts. From initial project analysis, design and equipment selection to engineering, production and plant commissioning, and from operator training to entire lifecycle support, GEA’s service team and process performance experts will be with you every step of the way.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like